Fenwick & West represented BILL Holdings, Inc. in the offering, and Wilson Sonsini Goodrich & Rosati represented the initial purchasers. BILL Holdings, Inc. (NYSE: BILL), a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represents Pacific Biosciences of California, Inc. on the transaction. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB), a leading developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Neptune Medical on the transaction. Neptune Medical, a leader in medical device innovation, announced the closing of a $97 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised TravelPerk on the transaction, and Bradley Arant Boult Cummings advised AmTrav. TravelPerk announced its acquisition of the industry-leading United States...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented BlackLine on the transaction. BlackLine, Inc. (Nasdaq: BL), announced the pricing of $600,000,000 aggregate principal amount of 1.00% convertible senior...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Block on the offering, and Simpson Thacher & Bartlett advised the initial purchasers. Block, Inc. (NYSE: SQ) (“Block” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lyft in the offering, and Goodwin Procter represented the initial purchasers. Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) closed its offering of 0.625%...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction. ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Seagate on the offering, while Davis Polk advised Morgan Stanley & Co. LLC. Seagate HDD Cayman (the “Company”), a subsidiary of Seagate Technology...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Micron on the offering, and Simpson Thacher advised the underwriters involved. Micron Technology, Inc. priced an offering of $600 million in aggregate principal...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Respiratory Motion on the deal. Senzime completed the acquisition of 100 percent of the shares in Respiratory Motion, as was made public on...
You must be a Standard 1 Year member to access this content.
